Literature DB >> 12409518

Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants.

Raymond W Redline1, Deanne Wilson-Costello, Maureen Hack.   

Abstract

To clarify the relationship between chorioamnionitis and chronic lung disease (CLD) in very low birth weight (VLBW) infants, we performed a retrospective cohort study of all inborn patients between 1995-1997 with gestational age (GA) less than 32 wk, birth weight less than 1.5 kg, survival to 36 wk adjusted GA, and placentas submitted to pathology (n = 371). Racial distribution as defined by the mother was 40% white/60% nonwhite. Prevalence of CLD, defined as O(2) dependence at 36 wk adjusted GA, was 30%. In a preliminary analysis GA and birth weight for GA (standard deviations from the mean, Z-score), considered together, were inversely related to CLD. After adjustment for GA and Z-score, other risk factors for CLD were white race, acute respiratory distress, pulmonary air leak, patent ductus arteriosus, and septicemia. Two placental lesions were inversely related to CLD: histologic chorioamnionitis and acute atherosis (a placental indicator of preeclampsia). Following multivariate analysis, independent risk factors for CLD were GA (OR, 0.6; 95% CI = 0.5, 0.7), birthweight for GA (OR, 0.4; 95% CI = 0.3, 0.6), white race (OR, 1.9; 95% CI = 1.0, 3.3), patent ductus arteriosus (OR, 2.0; 95% CI = 1.0, 3.5), and pulmonary air leak (OR, 3.0; 95% CI = 1.3, 7.1). Acute atherosis was inversely related to CLD (OR, 0.2; 95% CI = 0.1, 0.8). Chorioamnionitis was stratified by subtype and again no association with CLD was seen in the population as a whole. Finally, chorioamnionitis of all subtypes tended to be increased in white infants and decreased in black infants with CLD. This dichotomy was not explained by differences in death rates, acute respiratory distress, intubation on d 2 of life, or total duration of assisted ventilation. We conclude that while chorioamnionitis was not a risk factor for CLD in our total population, racial differences in its relationship to CLD are worthy of further study.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12409518     DOI: 10.1203/00006450-200211000-00017

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  25 in total

1.  Surfactant use based on the oxygenation response to lung recruitment during HFOV in VLBW infants.

Authors:  Pierre Tissières; Patrick Myers; Maurice Beghetti; Michel Berner; Peter C Rimensberger
Journal:  Intensive Care Med       Date:  2010-03-16       Impact factor: 17.440

2.  Maternal/fetal mortality and fetal growth restriction: role of nitric oxide and virulence factors in intrauterine infection in rats.

Authors:  Katarzyna Wroblewska-Seniuk; Stella Nowicki; Chantal Le Bouguénec; Bogdan Nowicki; Chandra Yallampalli
Journal:  Am J Obstet Gynecol       Date:  2011-02-23       Impact factor: 8.661

Review 3.  Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?

Authors:  Clyde J Wright; Haresh Kirpalani
Journal:  Pediatrics       Date:  2011-06-06       Impact factor: 7.124

4.  Placental pathologic changes of maternal vascular underperfusion in bronchopulmonary dysplasia and pulmonary hypertension.

Authors:  K K Mestan; J Check; L Minturn; S Yallapragada; K N Farrow; X Liu; E Su; N Porta; N Gotteiner; L M Ernst
Journal:  Placenta       Date:  2014-05-20       Impact factor: 3.481

5.  Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management.

Authors:  J M Brooks; J N Travadi; S K Patole; D A Doherty; K Simmer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-05       Impact factor: 5.747

Review 6.  Perinatal inflammation and lung injury.

Authors:  Rose Marie Viscardi
Journal:  Semin Fetal Neonatal Med       Date:  2011-09-08       Impact factor: 3.926

7.  Moderate postnatal hyperoxia accelerates lung growth and attenuates pulmonary hypertension in infant rats after exposure to intra-amniotic endotoxin.

Authors:  Jen-Ruey Tang; Gregory J Seedorf; Vincent Muehlethaler; Deandra L Walker; Neil E Markham; Vivek Balasubramaniam; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-08-13       Impact factor: 5.464

Review 8.  The association between hypertensive disorders in pregnancy and bronchopulmonary dysplasia: a systematic review.

Authors:  Guang-Liang Bi; Fei-Li Chen; Wei-Min Huang
Journal:  World J Pediatr       Date:  2013-11-14       Impact factor: 2.764

9.  Baseline TNFα operational capacity in fetal and maternal circulation prior to the onset of labor: "tuned for different purposes".

Authors:  Jacobo L Santolaya; Lindsay Kugler; Lissa Francois; Valeria Di Stefano; Gary A Ebert; Roman Wolf; Bingbing Wang; Joaquín Santolaya-Forgas
Journal:  Reprod Sci       Date:  2013-01-03       Impact factor: 3.060

10.  Chorioamnionitis increases matrix metalloproteinase-8 concentrations in bronchoalveolar lavage fluid from preterm babies.

Authors:  A E Curley; D G Sweet; K J MacMahon; C M O'Connor; H L Halliday
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-01       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.